| 1. | | Recruiting | Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer
Conditions: stage II squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the oropharynx; ... |
| 2. | | Recruiting | Surgery and Radiation Therapy With or Without Interleukin-2 in Treating Patients With Cancer of the Mouth or Oropharynx
Conditions: stage II squamous cell carcinoma of the lip and oral cavity; stage III squamous cell carcinoma of the lip and oral cavity; ... |
| 3. | | Recruiting | Phase I Trial of Gefitinib, Taxol, and Radiation Therapy to Treat Head and Neck Cancer
Conditions: Carcinoma, Squamous Cell; Head and Neck Neoplasms |
| 4. | | Recruiting | Study Of Zd1839 (Iressa™) Versus Methotrexate For Previously Treated Patients With Squamous Cell Carcinoma Of The Head And Neck
Conditions: Carcinoma, Squamous Cell; Neoplasms, Squamous Cell; Head and Neck Neoplasms |
| 5. | | Recruiting | Effectiveness and Safety of INGN 201 in Combination with Chemotherapy Versus Chemotherapy Alone
Condition: Carcinoma, Squamous Cell |
| 6. | | Recruiting | Study to Compare the Overall Survival of Patients Receiving INGN 201 (study drug) with Patients Receiving Methotrexate
Condition: Carcinoma, Squamous Cell |
| 7. | | Recruiting | Cytochlor and Tetrahydrouridine as Radiosensitizers Combined With Radiation Therapy in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity (Mouth) or Oropharynx (Throat)
Conditions: stage III squamous cell carcinoma of the lip and oral cavity; stage III squamous cell carcinoma of the oropharynx; ... |
| 8. | | Recruiting | Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer
Conditions: oral complications of chemotherapy and head/neck radiation; radiation toxicity; stage I squamous cell carcinoma of the nasopharynx; ... |
| 9. | | Recruiting | Gene Therapy and Surgery Followed by Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Cancer of the Mouth or Throat
Conditions: stage III squamous cell carcinoma of the lip and oral cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ... |
| 10. | | Recruiting | A Phase I Study of Concomitant Therapy with Proteasome Inhibitor PS-341 and Radiation in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Condition: Squamous Cell Carcinoma |
| 11. | | Recruiting | Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer
Conditions: stage II lymphoepithelioma of the nasopharynx; stage III lymphoepithelioma of the nasopharynx; stage IV lymphoepithelioma of the nasopharynx; ... |
| 12. | | Recruiting | High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer
Conditions: stage II lymphoepithelioma of the nasopharynx; stage II squamous cell carcinoma of the nasopharynx; stage III lymphoepithelioma of the nasopharynx; ... |
| 13. | | Recruiting | Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; metastatic squamous neck cancer with occult primary; Nasopharyngeal Cancer; ... |
| 14. | | Recruiting | Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; metastatic squamous neck cancer with occult primary; ... |
| 15. | | Recruiting | Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer
Conditions: stage I squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the lip and oral cavity |
| 16. | | Recruiting | Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer
Conditions: stage II squamous cell carcinoma of the oropharynx; stage III squamous cell carcinoma of the oropharynx; radiation toxicity |
| 17. | | Recruiting | Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx
Conditions: stage III lymphoepithelioma of the nasopharynx; stage IV squamous cell carcinoma of the nasopharynx; ... |
| 18. | | Recruiting | Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients with Primary Anal Cancer
Conditions: Anal Cancer; basaloid carcinoma of the anus; cloacogenic carcinoma of the anus; squamous cell carcinoma of the anus |
| 19. | | Not yet recruiting | Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer
Conditions: cervical adenocarcinoma; Cervical Cancer; cervical squamous cell carcinoma |
| 20. | | Recruiting | Docetaxel With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
Condition: Head and Neck Cancer |
| 21. | | Recruiting | Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck
Conditions: Drug Toxicity; female reproductive cancer; Head and Neck Cancer; thorax and respiratory cancer |
| 22. | | Recruiting | Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases
Conditions: Endocrine Cancer; Gastrointestinal Cancer; Head and Neck Cancer; metastatic cancer |
| 23. | | Recruiting | Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer
Condition: Head and Neck Cancer |
| 24. | | Recruiting | EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer
Condition: Head and Neck Cancer |
| 25. | | Recruiting | Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer
Conditions: Head and Neck Cancer; oral complications of cancer and cancer therapy; radiation toxicity |
| 26. | | Recruiting | Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
Condition: Head and Neck Cancer |
| 27. | | Recruiting | Radiation Therapy in Treating Patients With Head and Neck Cancer
Conditions: Head and Neck Cancer; skin tumor |
| 28. | | Recruiting | ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer
Conditions: lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer |
| 29. | | Recruiting | Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of cancer and cancer therapy; ... |
| 30. | | Recruiting | 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors
Condition: Cancer |
| 31. | | Recruiting | Capecitabine Combined with Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Breast Cancer; Gastrointestinal Cancer; Head and Neck Cancer; thorax and respiratory cancer; unclassified and other cancer |
| 32. | | Recruiting | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer
Condition: Cancer |
| 33. | | Recruiting | Fruit and Vegetable Extracts in Treating Patients With Stage I, Stage II, Stage III, or Stage IVa Head and Neck Cancer
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer |
| 34. | | Recruiting | Benzydamine in Treating Radiation-Induced Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Cancer of the Oral Cavity, Oropharynx, and/or Nasopharynx
Conditions: lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of chemotherapy and head and neck radiation; Oropharyngeal Cancer |
| 35. | | Recruiting | RK-0202 in Preventing Oral Mucositis in Patients Who are Undergoing Radiation Therapy for Cancer of the Mouth, Throat, or Salivary Glands
Conditions: lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of cancer and cancer therapy; Oropharyngeal Cancer; radiation toxicity; ... |
| 36. | | Recruiting | Flavopiridol in Treating Patients With Metastatic or Unresectable Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Mesothelioma, Renal Cell Carcinoma (Kidney Cancer), Squamous Cell Carcinoma of the Head and Neck, Small Cell Lung Cancer, or Invasive Breast Cancer
Conditions: Breast Cancer; Head and Neck Cancer; hematopoietic and lymphoid cancer; kidney and urinary cancer; thorax and respiratory cancer |
| 37. | | Recruiting | Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
Condition: Head and Neck Cancer |
| 38. | | Recruiting | Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
Condition: Head and Neck Cancer |
| 39. | | Recruiting | Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin
Conditions: adult solid tumor; Breast Cancer; Head and Neck Cancer; hematopoietic and lymphoid cancer; skin tumor |
| 40. | | Recruiting | Adjuvant Erlotinib After Completing Chemoradiotherapy in Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Condition: Head and Neck Cancer |
| 41. | | Recruiting | Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer
Conditions: Head and Neck Cancer; thorax and respiratory cancer |
| 42. | | Recruiting | Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
Conditions: Head and Neck Cancer; thorax and respiratory cancer |
| 43. | | Recruiting | Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Condition: Head and Neck Cancer |
| 44. | | Recruiting | Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Condition: Head and Neck Cancer |
| 45. | | Recruiting | FR901228 in Treating Patients With Unresectable Recurrent or Metastatic Squamous Cell Carcinoma (Cancer) of the Head and Neck
Condition: Head and Neck Cancer |
| 46. | | Recruiting | Ixabepilone in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Condition: Head and Neck Cancer |
| 47. | | Recruiting | Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
Condition: Cancer |
| 48. | | Recruiting | UCN-01 and Irinotecan in Treating Patients With Metastatic or Unresectable Solid Tumors
Condition: Cancer |
| 49. | | Recruiting | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
Condition: Cancer |
| 50. | | Recruiting | Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
Condition: Cancer |
